Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01871909 · ClinicalTrials.gov registry record
Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 50
- Enrollment target
NCT01871909: Completed study, sponsored by University of Colorado, Denver.
NCT01871909 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01871909 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Lower body negative pressure (LBNP) is a laboratory model used to study hemorrhage in humans. The investigators hypothesize that the physiologic changes that occur with application of LBNP mimic those observed in bleeding and hemodynamically unstable trauma patients, and that LBNP is a truly valid model of human hemorrhage.
Primary Outcome
Compare physiologic waveform data obtained from bleeding and hemodynamically unstable trauma patients to existing data collected from LBNP subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-12 |
What the finished NCT01871909 record still lists
NCT01871909 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01871909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01871909 about?
NCT01871909 is a clinical study titled "Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients". Lower body negative pressure (LBNP) is a laboratory model used to study hemorrhage in humans. The investigators hypothesize that the physiologic changes that occur with application of LBNP mimic those observed in bleeding and hemodynamically unstable trauma patients, and that LBNP is a truly valid m...
What is the current status of trial NCT01871909?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-10. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01871909?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia